Replies to post #195294 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

They signed a deal with Cantor quite a while back.. IMO it will execute differently than the LPC deal.

I'm expecting bigger blocks and a higher price.

Institutional interest is low because long retail isn't selling.

[Gernee20]

Gator- at end of 2018, we were told by Missling we will start a 3-71 ph1 Trial. The funds needed to get this off the ground and running will be a smart investment, as we will have our 2nd molecule in clinical trials which mitigate the risk if 2-73 fails to prove efficacy in our 4 new trials. We don’t know where the funds are coming from, however I trust the management to make these kinds of decisions, especially when looking at there track record in getting 4 trials up and running with minimal dilution.